• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估宫颈癌手术后女性压力性尿失禁的发生率和危险因素:一项单中心回顾性研究。

Assessment of the Incidence and Risk Factors of Stress Urinary Incontinence in Women after Cervical Cancer Surgery: A Single-Centre Retrospective Study.

机构信息

Department of Gynaecology and Obstetrics, The First Affiliated Hospital of Qiqihar Medical University, 161041 Qiqihar, Heilongjiang, China.

Physical Examination Center, The First Affiliated Hospital of Qiqihar Medical University, 161041 Qiqihar, Heilongjiang, China.

出版信息

Arch Esp Urol. 2024 Sep;77(8):921-927. doi: 10.56434/j.arch.esp.urol.20247708.130.

DOI:10.56434/j.arch.esp.urol.20247708.130
PMID:39385489
Abstract

BACKGROUND

Stress urinary incontinence (SUI) is a common postoperative complication that significantly affects the quality of life in women who have undergone radical hysterectomy for cervical cancer. This study evaluates the incidence and risk factors associated with SUI in women after cervical cancer surgery.

METHODS

This case-control study included women diagnosed with cervical cancer who underwent radical hysterectomy at our hospital between May 2020 and May 2023. Participants were divided into two groups based on the presence of postoperative SUI, namely the SUI group and the SUI-free group. Inclusion criteria required the absence of preoperative urinary incontinence and stable vital signs. Data were collected on demographic characteristics, tumour histology and staging, urodynamic parameters, and intraoperative and postoperative factors.

RESULTS

Ninety-seven patients with cervical cancer who underwent radical hysterectomy were divided into two groups: The SUI group (n = 27) and the SUI-free group (n = 70), with an SUI incidence of 27.8% in the study population. Significant differences between the SUI and SUI-free groups were observed in menopausal status ( = 0.026), chronic constipation ( = 0.011), and tumour diameter ( < 0.001). Urodynamic assessments revealed a higher maximum urinary flow rate (Qmax) in the SUI group compared to the SUI-free group (21.36 ± 6.41 vs. 17.38 ± 5.18 mL/s; = 0.002). Logistic regression analysis identified menopause (odds ratio (OR) = 7.700, 95% confidence interval (CI) = 1.256-47.192), chronic constipation (OR = 9.918, 95% CI = 1.387-70.911), Qmax (OR = 1.302, 95% CI = 1.061-1.598), and surgery duration (OR = 1.040, 95% CI = 1.001-1.081) as independent protective factors.

CONCLUSIONS

SUI is a significant postoperative complication in women undergoing cervical cancer surgery. Menopause, chronic constipation, tumour diameter, Qmax, and surgery duration were independent risk factors.

摘要

背景

压力性尿失禁(SUI)是宫颈癌根治术后常见的术后并发症,严重影响患者的生活质量。本研究旨在评估宫颈癌术后女性发生 SUI 的发生率及相关危险因素。

方法

本病例对照研究纳入了 2020 年 5 月至 2023 年 5 月在我院接受根治性子宫切除术的宫颈癌患者。根据术后是否发生 SUI,将患者分为 SUI 组(n=27)和非 SUI 组(n=70)。纳入标准为术前无尿失禁且生命体征稳定。收集患者的人口统计学特征、肿瘤组织学和分期、尿动力学参数以及术中、术后相关因素。

结果

本研究共纳入 97 例宫颈癌患者,分为 SUI 组(n=27)和非 SUI 组(n=70),研究人群中 SUI 的发生率为 27.8%。SUI 组和非 SUI 组在绝经状态( =0.026)、慢性便秘( =0.011)和肿瘤直径( <0.001)方面存在显著差异。尿动力学评估显示,SUI 组的最大尿流率(Qmax)高于非 SUI 组(21.36±6.41 vs. 17.38±5.18 mL/s; =0.002)。Logistic 回归分析显示,绝经(优势比(OR)=7.700,95%置信区间(CI)=1.256-47.192)、慢性便秘(OR=9.918,95%CI=1.387-70.911)、Qmax(OR=1.302,95%CI=1.061-1.598)和手术时间(OR=1.040,95%CI=1.001-1.081)是 SUI 的独立保护因素。

结论

SUI 是宫颈癌根治术后的一种严重术后并发症。绝经、慢性便秘、肿瘤直径、Qmax 和手术时间是独立的危险因素。

相似文献

1
Assessment of the Incidence and Risk Factors of Stress Urinary Incontinence in Women after Cervical Cancer Surgery: A Single-Centre Retrospective Study.评估宫颈癌手术后女性压力性尿失禁的发生率和危险因素:一项单中心回顾性研究。
Arch Esp Urol. 2024 Sep;77(8):921-927. doi: 10.56434/j.arch.esp.urol.20247708.130.
2
Incidence and risk factors of stress urinary incontinence after laparoscopic hysterectomy.腹腔镜子宫切除术后压力性尿失禁的发生率及危险因素。
BMC Womens Health. 2024 Feb 8;24(1):105. doi: 10.1186/s12905-024-02942-2.
3
Incidence and risk factors of postoperative stress urinary incontinence following laparoscopic sacrocolpopexy in patients with negative preoperative prolapse reduction stress testing.术前脱垂复位压力测试阴性患者腹腔镜骶骨阴道固定术后压力性尿失禁的发生率及危险因素
Int Urogynecol J. 2013 Mar;24(3):485-91. doi: 10.1007/s00192-012-1888-7. Epub 2012 Jul 24.
4
Post radical hysterectomy urinary incontinence: a prospective study of transurethral bulking agents injection.根治性子宫切除术后尿失禁:经尿道填充剂注射的前瞻性研究
Gynecol Oncol. 2009 Jan;112(1):90-4. doi: 10.1016/j.ygyno.2008.09.022. Epub 2008 Oct 25.
5
[Influence of urodynamic factors on urinary retention in patients with cervical carcinoma after radical hysterectomy].[尿动力学因素对宫颈癌根治术后患者尿潴留的影响]
Zhonghua Fu Chan Ke Za Zhi. 2010 Sep;45(9):677-81.
6
Sexual, bladder and bowel function following different minimally invasive techniques of radical hysterectomy in patients with early-stage cervical cancer.早期宫颈癌患者不同微创根治性子宫切除术方法对性功能、膀胱和肠道功能的影响。
Clin Transl Oncol. 2021 Nov;23(11):2335-2343. doi: 10.1007/s12094-021-02632-7. Epub 2021 May 18.
7
Risk factors for catheter-associated urinary tract infections following radical hysterectomy for cervical cancer.根治性子宫切除术治疗宫颈癌后与导尿管相关的尿路感染的危险因素。
Am J Obstet Gynecol. 2023 Jun;228(6):718.e1-718.e7. doi: 10.1016/j.ajog.2023.02.019. Epub 2023 Feb 28.
8
Predictors for de novo stress urinary incontinence following pelvic reconstructive surgery with mesh.盆腔网状物重建手术后新发压力性尿失禁的预测因素。
Eur J Obstet Gynecol Reprod Biol. 2020 Oct;253:15-20. doi: 10.1016/j.ejogrb.2020.07.033. Epub 2020 Jul 22.
9
Stress Urinary Incontinence After Operations for Uterine Prolapse: A Nationwide Cohort Study.子宫脱垂手术后的压力性尿失禁:一项全国性队列研究。
Urogynecology (Phila). 2023 Feb 1;29(2):121-127. doi: 10.1097/SPV.0000000000001264.
10
Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early-stage cervical cancer.根治性子宫切除术治疗早期宫颈癌后预防膀胱功能障碍的术后干预。
Cochrane Database Syst Rev. 2021 Jan 25;1(1):CD012863. doi: 10.1002/14651858.CD012863.pub2.